06.10.2021 13:05:33
|
BD Says Rotarex Atherectomy System Receives Expanded 510(k) Clearance From FDA - Quick Facts
(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Wednesday that it has received 510(k) clearance for expanded indications from the U.S. Food and Drug Administration (FDA) for the Rotarex Atherectomy System.
The Rotarex Atherectomy System is a rotational excisional device that is built to remove and aspirate varying lesion morphologies including plaque and thrombus in the peripheral arteries.
The Rotarex System, already cleared for use in native arterial vessels, now has the expanded indications to treat within peripheral arteries fitted with stents, stent grafts, and native or artificial bypasses.
The FDA clearance of the Rotarex Atherectomy System's new expanded indications follows more than 10 years of real-world clinical experience involving the treatment of thousands of patients globally.
Now, physicians can use a proven tool to address some of their most challenging peripheral arterial disease (PAD) lesions, including the treatment of in-stent restenosis.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Becton, Dickinson & Co. (BD)mehr Nachrichten
29.01.25 |
S&P 500-Titel Becton, Dickinson-Aktie: So viel hätten Anleger mit einem Investment in Becton, Dickinson von vor 3 Jahren verloren (finanzen.at) | |
28.01.25 |
Dienstagshandel in New York: S&P 500 letztendlich mit Gewinnen (finanzen.at) | |
28.01.25 |
Zuversicht in New York: Das macht der S&P 500 nachmittags (finanzen.at) | |
28.01.25 |
Optimismus in New York: So bewegt sich der S&P 500 aktuell (finanzen.at) | |
28.01.25 |
Handel in New York: S&P 500 zum Handelsstart ohne Schwung (finanzen.at) | |
27.01.25 |
Verluste in New York: S&P 500 verbucht zum Ende des Montagshandels Verluste (finanzen.at) | |
27.01.25 |
Handel in New York: S&P 500 in Rot (finanzen.at) | |
27.01.25 |
Verluste in New York: S&P 500 liegt am Montagmittag im Minus (finanzen.at) |
Analysen zu Becton, Dickinson & Co. (BD)mehr Analysen
Aktien in diesem Artikel
Becton, Dickinson & Co. (BD) | 236,50 | -0,21% |